The subtypes are not as well defined in pediatric GBM where genetic profiling revealed PDGFRα as the predominant focal amplification target and gene expression analyses indicated deregulation of PDGFRα signaling plays an important role in tumor development (Paugh et al., 2010). This evidence concerns the gene PDGFRA and neoplasm.